Next, we correlated PFKM and autophagy–mitophagy markers (MAP1LC3B and BNIP3) with the most common genetic alterations in AML patients among which we chose NPM1 and FLT3, accounting for 22% and 28% of the TCGA cohort, respectively. The gene discussed is FLT3; the disease is acute myeloid leukemia.